The death and in memorium notices from Swansea this week as families remember loved ones walesonline.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from walesonline.co.uk Daily Mail and Mail on Sunday newspapers.
Srinagar: An online workshop on research methodology concluded at the University of Kashmir on Saturday.
The five-day workshop was organised by the varsity’s Shaikh-ul Aalam Centre for Multidisciplinary Studies (SACMS) in collaboration with Ibn Arabi Society Kashmir to help young scholars of Humanities and Social Sciences disciplines to enhance their research skills and broaden their perspectives on research.
Chairman SACMS Prof G
Neither QUAD nor RIC - Jammu Kashmir Latest News | Tourism dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.
Formerly Professor of Food and Beverage and Service Operations Management at EHL, Ian Scarth has a background in strategic development and leadership within the hotel and hospitality sectors. In this article he gives his views on what it means to be a purpose-driven organisation.
WTO versus Humankind?
Bharat Jhunjhunwala
In the main two vaccines are available to us today Covishield developed by AstraZeneca and produced under its license by Serum Institute of India; and Covaxin developed by Bharat Biotech. Serum Institute has to pay one-half of the sale price to AstraZeneca as royalty; or it has to pay Rs 75 as royalty if it sells Covishield to the Central Government at Rs 150. Serum Institute says that it is not economic for it to produce Covishield in the balance Rs 75. For this reason, they have offered to sell Covishield only at Rs 300 to the States and at a higher price to the private buyers. In this way the States will be buying Covishield at Rs 300 and subsidizing the purchase by Center at Rs 150. The Center should act as father of the States. Instead it is acting as their opponent. This is a minor problem, however. Serum Institute is having to pay this huge amount of royalty because we have accepted Product Patents under the World Trade Organization